The JAK2 V617F mutation in lung cancer: caveat emptor
As acquisition of the JAK2 V617F is considered to be restricted to myeloid malignancies, the recurrent identification of this mutation in non-small cell lung cancer (NSCLC) merits discussion, particularly in the light of accumulating evidence which suggests that the JAK2 V617F may...
Saved in:
| Date: | 2018 |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2018
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |